Clinical Trial Update: Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and biological effects of intratumoral interferon gamma and a peptide-based vaccine in patients with melanoma. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon-gamma (interferon gamma)
• Peptide-based vaccine (peptide-based vaccine)

Snippet

Sponsor: Craig L Slingluff, Jr | Conditions: Melanoma | Phase 1 | Status: TERMINATED